Jbog--I am positive on IMCL's anti-VEGFR2 programs. Recently, Rebecca @Imclone IR sent me the slides from a recent Rodman & Renshaw investor's conference (Dec 2006?). I thought it was interesting that there was no mention of the the CDP-791 program. The presentation did mention Imclone's anti-VEGFR2 antibody. Not sure what it means (if anything).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.